These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 39041256)
1. RBM3 Inhibits the Cell Cycle of Cutaneous Squamous Cell Carcinoma through the PI3K/AKT Signaling Pathway. Huang Y; Sun W; Zhu D; Liu L; Feng J; Yi Q Curr Mol Pharmacol; 2024; 17():e18761429323760. PubMed ID: 39041256 [TBL] [Abstract][Full Text] [Related]
2. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway. Lu D; Sun L; Li Z; Mu Z Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR. Mei XL; Zhong S Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166 [TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation. Zhou K; Wu C; Cheng W; Zhang B; Wei R; Cheng D; Li Y; Cao Y; Zhang W; Yao Z; Zhang X Cell Death Dis; 2024 Apr; 15(4):252. PubMed ID: 38589352 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway. Ci C; Wu C; Lyu D; Chang X; He C; Liu W; Chen L; Ding W Clin Exp Dermatol; 2020 Mar; 45(2):194-201. PubMed ID: 31419330 [TBL] [Abstract][Full Text] [Related]
6. circ_0001821 Contributes to the Development of Cutaneous Squamous Cell Carcinoma by Regulating MicroRNA-148a-3p/EGFR Axis and Activating Phosphatidylinositol 3-Kinase/Akt Pathway. Zhang Z; Deng X Mol Cell Biol; 2022 Mar; 42(3):e0008921. PubMed ID: 35191745 [TBL] [Abstract][Full Text] [Related]
7. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses. Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041 [TBL] [Abstract][Full Text] [Related]
8. Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway. Huang X; Zhang S; Wang W Tissue Cell; 2022 Jun; 76():101789. PubMed ID: 35338984 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway. Tian K; Liu W; Zhang J; Fan X; Liu J; Zhao N; Yao C; Miao G Cell Mol Biol Lett; 2020; 25():12. PubMed ID: 32161621 [TBL] [Abstract][Full Text] [Related]
10. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma. Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway. Wang Q; Zhang X; Song X; Zhang L Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142 [TBL] [Abstract][Full Text] [Related]
12. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway. Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma. Liu D; Feng X; Wu X; Li Z; Wang W; Tao Y; Xia Y Tumour Biol; 2013 Dec; 34(6):3773-83. PubMed ID: 23812766 [TBL] [Abstract][Full Text] [Related]
14. microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2. Ma X; Wu D; Zhang X; Shao X; Hu G Technol Cancer Res Treat; 2020; 19():1533033820980098. PubMed ID: 33280526 [TBL] [Abstract][Full Text] [Related]
15. Role of Xeroderma Pigmentosum Group D in Cell Cycle and Apoptosis in Cutaneous Squamous Cell Carcinoma A431 Cells. Liu OG; Xiong XY; Li CM; Zhou XS; Li SS Med Sci Monit; 2018 Jan; 24():453-460. PubMed ID: 29362353 [TBL] [Abstract][Full Text] [Related]
16. Sanguinarine Triggers Apoptosis in Cutaneous Squamous Cell Carcinoma Cells through Reactive Oxygen Species-Dependent c-Jun N-Terminal Kinase Signaling Pathway. Patil K; Khan AQ; Ahmad F; Kuttikrishnan S; Anver R; Mateo JM; Ahmad A; Bhat AA; Buddenkotte J; Steinhoff M; Uddin S Front Biosci (Landmark Ed); 2024 Jan; 29(1):40. PubMed ID: 38287817 [TBL] [Abstract][Full Text] [Related]
17. NPHS2-6 drives cervical squamous cell carcinoma (CSCC) progression via hsa-miR-1323/SMC1B axis to activate PI3K-Akt pathway. Li F; Wang Y; Wen M; Aizezi G; Yuan J; Zhou T; Shen G Clin Transl Oncol; 2024 Jan; 26(1):245-259. PubMed ID: 37322227 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis. Wang L; Hou S; Li J; Tian T; Hu R; Yu N Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022 [TBL] [Abstract][Full Text] [Related]
19. [Yes-associated protein (YAP) promotes invasion and migration of cutaneous squamous cell carcinoma cells by activating the PI3K/AKT pathway]. Li Z; Yang F; Jin X; Wang X; Chen T; Quan C Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):244-251. PubMed ID: 38512035 [TBL] [Abstract][Full Text] [Related]
20. Triptolide Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma Zheng Z; Yan G; Xi N; Xu X; Zeng Q; Wu Y; Zheng Y; Zhang G; Wang X Anticancer Agents Med Chem; 2023; 23(13):1596-1604. PubMed ID: 37056067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]